Members Sign In

Archives

Unknown Recruitment Status

A clinical study in ClinicalTrials.gov with a status of Recruiting; Not yet recruiting; or Active, not recruiting and whose status has not been confirmed within the past 2 years. Studies […]

READ MORE

Type II Error

A Type II error (also known as a false-negative error) is committed when a real effect is not detected between groups, when in fact it is present. (Pfizer)

READ MORE

Type I Error

A Type I error (also known as a false-positive error) is committed when a statistical difference between groups is declared when in fact there is none. (Pfizer)

READ MORE

Trial Initiation Visit

Finalize the preparation of a study in the form of a meeting that all study staff may attend. (Pfizer)

READ MORE

Trial Design

Features of the clinical trial that are included in the protocol, e.g.: Number of subjects to be enrolled (planned number or event-dependent, e.g., number of deaths) Controls (placebo, active) included […]

READ MORE

Treatment Period

Time during which the subject receives a study treatment, whether experimental or control. (Pfizer)

READ MORE

Treatment Groups

Subjects that make up the experimental and control groups. (Pfizer)

READ MORE

Study Title Acronym

The acronym or initials used to identify a clinical study, if provided. For example, the title acronym for the Women’s Health Initiative is “WHI”. (See also Acronym data element on […]

READ MORE

Time Frame for Outcome Measures

The points in time at which the outcome measure is assessed. These are planned before the clinical study starts and listed in the protocol. (See also Primary and Secondary Outcome […]

READ MORE

Termination

The clinical study has stopped recruiting or enrolling participants early and will not start again. Participants are no longer being examined or treated. A type of Recruitment Status.

READ MORE